These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 21677063)

  • 1. Production of 22-hydroxy metabolites of vitamin d3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells.
    Tuckey RC; Li W; Shehabi HZ; Janjetovic Z; Nguyen MN; Kim TK; Chen J; Howell DE; Benson HA; Sweatman T; Baldisseri DM; Slominski A
    Drug Metab Dispos; 2011 Sep; 39(9):1577-88. PubMed ID: 21677063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation.
    Zbytek B; Janjetovic Z; Tuckey RC; Zmijewski MA; Sweatman TW; Jones E; Nguyen MN; Slominski AT
    J Invest Dermatol; 2008 Sep; 128(9):2271-80. PubMed ID: 18368131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes.
    Janjetovic Z; Tuckey RC; Nguyen MN; Thorpe EM; Slominski AT
    J Cell Physiol; 2010 Apr; 223(1):36-48. PubMed ID: 20020487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activity.
    Li W; Chen J; Janjetovic Z; Kim TK; Sweatman T; Lu Y; Zjawiony J; Tuckey RC; Miller D; Slominski A
    Steroids; 2010 Dec; 75(12):926-35. PubMed ID: 20542050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of 1alpha-hydroxyvitamin D3 by cytochrome P450scc to biologically active 1alpha,20-dihydroxyvitamin D3.
    Tuckey RC; Janjetovic Z; Li W; Nguyen MN; Zmijewski MA; Zjawiony J; Slominski A
    J Steroid Biochem Mol Biol; 2008 Dec; 112(4-5):213-9. PubMed ID: 19000766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc.
    Tuckey RC; Li W; Zjawiony JK; Zmijewski MA; Nguyen MN; Sweatman T; Miller D; Slominski A
    FEBS J; 2008 May; 275(10):2585-96. PubMed ID: 18410379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative pathway of vitamin D metabolism. Cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2.
    Slominski A; Semak I; Wortsman J; Zjawiony J; Li W; Zbytek B; Tuckey RC
    FEBS J; 2006 Jul; 273(13):2891-901. PubMed ID: 16817851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purified mouse CYP27B1 can hydroxylate 20,23-dihydroxyvitamin D3, producing 1alpha,20,23-trihydroxyvitamin D3, which has altered biological activity.
    Tang EK; Li W; Janjetovic Z; Nguyen MN; Wang Z; Slominski A; Tuckey RC
    Drug Metab Dispos; 2010 Sep; 38(9):1553-9. PubMed ID: 20554701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of 20S-hydroxyvitamin D
    Lin Z; Marepally SR; Goh ESY; Cheng CYS; Janjetovic Z; Kim TK; Miller DD; Postlethwaite AE; Slominski AT; Tuckey RC; Peluso-Iltis C; Rochel N; Li W
    Sci Rep; 2018 Jan; 8(1):1478. PubMed ID: 29367669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1).
    Guryev O; Carvalho RA; Usanov S; Gilep A; Estabrook RW
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14754-9. PubMed ID: 14657394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of 20-hydroxyvitamin D3 and 20,23-dihydroxyvitamin D3 by rat and human CYP24A1.
    Tieu EW; Li W; Chen J; Kim TK; Ma D; Slominski AT; Tuckey RC
    J Steroid Biochem Mol Biol; 2015 May; 149():153-65. PubMed ID: 25727742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1.
    Tang EK; Chen J; Janjetovic Z; Tieu EW; Slominski AT; Li W; Tuckey RC
    Drug Metab Dispos; 2013 May; 41(5):1112-24. PubMed ID: 23454830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evidence for a novel pathway of vitamin D₃ metabolism initiated by P450scc and modified by CYP27B1.
    Slominski AT; Kim TK; Shehabi HZ; Semak I; Tang EK; Nguyen MN; Benson HA; Korik E; Janjetovic Z; Chen J; Yates CR; Postlethwaite A; Li W; Tuckey RC
    FASEB J; 2012 Sep; 26(9):3901-15. PubMed ID: 22683847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORα and RORγ.
    Slominski AT; Kim TK; Hobrath JV; Oak ASW; Tang EKY; Tieu EW; Li W; Tuckey RC; Jetten AM
    J Steroid Biochem Mol Biol; 2017 Oct; 173():42-56. PubMed ID: 27693422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
    Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
    Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
    Ellison TI; Eckert RL; MacDonald PN
    J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity.
    Slominski AT; Janjetovic Z; Fuller BE; Zmijewski MA; Tuckey RC; Nguyen MN; Sweatman T; Li W; Zjawiony J; Miller D; Chen TC; Lozanski G; Holick MF
    PLoS One; 2010 Mar; 5(3):e9907. PubMed ID: 20360850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis and Biological Activities of Novel Gemini 20S-Hydroxyvitamin D3 Analogs.
    Lin Z; Marepally SR; Kim TK; Janjetovic Z; Oak AS; Postlethwaite AE; Myers LK; Tuckey RC; Slominski AT; Miller DD; Li W
    Anticancer Res; 2016 Mar; 36(3):877-86. PubMed ID: 26976974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-6 functionalized analogs of 25-hydroxyvitamin D3 and 1alpha,25-dihydroxyvitamin D3: synthesis and binding analysis with vitamin D-binding protein and vitamin D receptor.
    Addo JK; Swamy N; Ray R
    Steroids; 1999 Apr; 64(4):273-82. PubMed ID: 10399884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.